Cell Reports (Nov 2023)

Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling

  • Crissy Dudgeon,
  • Anthony Casabianca,
  • Chris Harris,
  • Charline Ogier,
  • Mélanie Bellina,
  • Stephany Fiore,
  • Agnes Bernet,
  • Benjamin Ducarouge,
  • David Goldschneider,
  • Xiaoyang Su,
  • Jason Pitarresi,
  • Aram Hezel,
  • Subhajyoti De,
  • Wade Narrow,
  • Fady Soliman,
  • Cory Shields,
  • Debora Barbosa Vendramini-Costa,
  • Orjola Prela,
  • Lan Wang,
  • Igor Astsaturov,
  • Patrick Mehlen,
  • Darren R. Carpizo

Journal volume & issue
Vol. 42, no. 11
p. 113369

Abstract

Read online

Summary: The biology of metastatic pancreatic ductal adenocarcinoma (PDAC) is distinct from that of the primary tumor due to changes in cell plasticity governed by a distinct transcriptome. Therapeutic strategies that target this distinct biology are needed. We detect an upregulation of the neuronal axon guidance molecule Netrin-1 in PDAC liver metastases that signals through its dependence receptor (DR), uncoordinated-5b (Unc5b), to facilitate metastasis in vitro and in vivo. The mechanism of Netrin-1 induction involves a feedforward loop whereby Netrin-1 on the surface of PDAC-secreted extracellular vesicles prepares the metastatic niche by inducing hepatic stellate cell activation and retinoic acid secretion that in turn upregulates Netrin-1 in disseminated tumor cells via RAR/RXR and Elf3 signaling. While this mechanism promotes PDAC liver metastasis, it also identifies a therapeutic vulnerability, as it can be targeted using anti-Netrin-1 therapy to inhibit metastasis using the Unc5b DR cell death mechanism.

Keywords